Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis
ConclusionsThe PK and PKPD analysis supports the use of MIPD to guide clinical dose decisions and reduce the incidence of VIPN. The current work can be used to support decisions with respect to dose selection and dose individualization in children receiving vincristine.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Cancer & Oncology | Child Development | Children | Drugs & Pharmacology | Neurology | Overdose | Pediatrics | Peripheral Neuropathy | Study